REGENXBIO's Nina Hunter, Ph.D. Details the Accelerated Approval Pathway for Gene Therapies

<p>REGENXBIO&apos;s VP of Regulatory and Science Policy, Nina Hunter, Ph.D., shares potential solutions to gene therapies&apos; regulatory roadblocks and why the accelerated approval pathway is so pertinent. </p>